IM Cannabis Has Decided Not To Make Remaining Installment Payments Installments By IMC Holdings Ltd., And As Such Will Transfer The 51% Shares Held By IMC Holdings Ltd Back To The Seller
IM Cannabis Has Decided Not To Make Remaining Installment Payments Installments By IMC Holdings Ltd., And As Such Will Transfer The 51% Shares Held By IMC Holdings Ltd Back To The Seller
IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
在以色列和德国开展业务的领先医用大麻公司 IM Cannabis Corp.（CSE: IMCC）（纳斯达克股票代码：IMCC）（“公司” 或 “IMC”）宣布，继2024年1月12日的新闻稿之后，该公司决定不向IMC Holdings Ltd分期支付剩余的分期付款（即含利息的5,873K新谢克尔或2,154万加元），因此将将IMC控股有限公司持有的51％的股份转让给卖方。
"With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential," said Oren Shuster, CEO of IMC. "With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment."
IMC首席执行官奥伦·舒斯特表示：“随着4月1日德国大麻合法化，我们将资源集中在德国市场，我们预计德国市场将呈现最大的增长潜力。”“由于我们的两个核心市场德国和以色列目前都在快速发展，我们需要确保将资源分配给我们期望获得最佳投资回报的增长机会。”